RA
TAK icon

Riversedge Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Riversedge Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$212K Buy
+11,652
New +$206K 0.03% 344

Other funds holding TAK

LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MLFP
MPS Loria Financial Planners Burr Ridge, Illinois $527M AUM 17.98% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
AP
Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return

Riversedge Advisors's TAK Position: Q3 2026 in Review

Riversedge Advisors opened a new position in Takeda Pharmaceutical (TAK) in Q3 2026: 11,652 shares worth $212K. The stake represents 0.03% of the portfolio and ranks #344 among its holdings.

26 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Riversedge Advisors held 11,652 shares of Takeda Pharmaceutical worth $212K as of Q3 2026.
  • Takeda Pharmaceutical was a new Riversedge Advisors position in Q3 2026.
  • Takeda Pharmaceutical made up 0.03% of Riversedge Advisors's portfolio in Q3 2026, its #344 holding.
  • 26 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Riversedge Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.